...

首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for Lymphomas

【24h】

Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for Lymphomas

机译：与移植后HLA匹配的相关供体（MRD）相比，使用移植后环磷酰胺（PT-CY）进行T细胞大量单倍体相关供体造血细胞移植（Haplo-HCT）的存活率

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 》 |2016年第1期| 共2页
作者
Karmali Reem; Ghosh Nilanjan; Rocha Vanderson G.; Ahn Kwang Woo; DiGilio Alyssa; Armand Philippe; Salit Rachel B.; Fenske Timothy S.; Smith Sonali M.; Sureda Anna; Wagner-Johnston Nina; Meade Javier Bolanos; Hamadani Mehdi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for Lymphomas [J] . Karmali Reem, Ghosh Nilanjan, Rocha Vanderson G., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016 ,第3Suppla1期

机译：与移植后HLA匹配的相关供体（MRD）相比，使用移植后环磷酰胺（PT-CY）进行T细胞大量单倍体相关供体造血细胞移植（Haplo-HCT）的存活率
2. Similar Survival Between Haploidentical T-Cell Replete Hematopoietic Transplantation (Haplo) with Post-Transplantation Cyclophosphamide (PT-CY) and Unrelated Cord Blood Transplant (UCBT) in Chile [J] . Sanchez Matias E., Negrete Francisca, Mosso Claudio, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016 ,第3Suppla1期

机译：智利同种异体的T细胞大量造血移植（Haplo）与移植后的环磷酰胺（PT-CY）和无关脐带血移植（UCBT）之间的相似存活率
3. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation [J] . BasheyA., ZhangX., SizemoreC.A., Journal of Clinical Oncology . 2013 ,第10期

机译：使用移植后的环磷酰胺进行T细胞补充HLA单倍型造血移植治疗恶性血液病，其结果与同期HLA匹配的相关和不相关供体移植的结果相同
4. DONOR-SPECIFIC (DSA) ANTI-DP ANTIBODIES ASSOCIATE WITH GRAFT FAILURE IN MATCHED UNRELATED DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION [C] . Stefan O. Ciurea, Fleur Aung, Pedro Cano, Clinical Histocompatibility Workshop. . 2010

机译：特异性（DSA）抗DP抗体与匹配的无关供体造血干细胞移植中的接枝衰竭相关联
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide results in outcomes similar to traditionally matched donors in active disease acute myeloid leukemia [O] . Joan How, Michael Slade, Khoan Vu, -1

机译：T细胞充足的外周血单核造血细胞移植与移植后环磷酰胺的治疗结果相似在活动性疾病急性髓性白血病中与传统匹配的供体相似
7. Survival after T-Cell Replete Haploidentical Related Donor Hematopoietic Cell Transplantation (Haplo-HCT) Using Post-Transplant Cyclophosphamide (PT-CY) Compared with HLA-Matched Related Donor (MRD) Transplant for Lymphomas [O] . Reem Karmali, Nilanjan Ghosh, Vanderson G. Rocha, 2016

机译：与HLA匹配的相关供体（MRD）移植进行淋巴瘤，使用后移植后环磷酰胺（PT-CY）进行T-Cell Replete Haploidentical相关供体造血细胞移植（HAPLO-HCT）。
8. Development of Augmented Leukemia/Lymphoma-Specific T-Cell Immunotherapy for Deployment with Haploidentical Hematopoietic Progenitor-Cell Transplant. [R] . Cooper, L. 2010

机译：发展增强白血病/淋巴瘤特异性T细胞免疫治疗部署与单倍体相合的造血祖细胞移植。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号